OCT 16, 2020 5:54 AM PDT

Chronic jet lag raises cancer risk

We all know how horrible it feels to have a bad night of sleep. That feeling is only intensified with jet lag because our bodies are trying to adjust to being awake when they think we should be sleeping. But you get over it, and no harm was done, right?

Wrong. New research published in Science Advances suggests that circadian rhythm disruptions like chronic jet lag have serious implications on the body’s ability to fight cancer. In such scenarios, the stressed cells resulting from chronic jet lag alter the microenvironment surrounding tumor cells, creating conditions favorable for tumor growth and limiting the body's natural immune defenses.

"A key takeaway from this study is that if someone has a proliferative disorder, in this case, melanoma, doing shift work or regularly changing time zones could exacerbate the problem by dampening immune system response to tumor growth," said corresponding author Carla Finkielstein, who is an associate professor at the Fralin Biomedical Research Institute at VTC and Virginia Tech's College of Science, as well as director of the Molecular Diagnostics Laboratory at the Fralin Biomedical Research Institute. "This research also helps explain why some tumors win the race when a person is exposed to the chronically stressful conditions that occur when the environment and the body's clocks are misaligned."

The researchers looked at how the “clock” genes in mice models with melanoma were affected by the manipulation of light. Because our bodies normally regulate our physiological and molecular clocks from signals based on consistent intervals of light and dark, the researchers exposed one group of mice to a normal circadian schedule and another group to a schedule simulating chronic jet lag.

Photo: Pixabay

"We combined two different approaches of chronobiology research to study the effects of circadian desynchronization on both tumor growth and immune rhythms, and we found a link," said corresponding author Diego Golombek, a professor at the National University of Quilmes in Argentina. "You need optimal rhythms in immune cells and immune humoral factors to quell rapid tumor growth. When circadian rhythms are chronically disrupted, these rhythms are impaired, inverted, or disappear entirely, which could help explain why the tumors were significantly larger in the desynchronized group."

The jet lagged group showed tumors almost 3 times the size of the control group. “Our findings show that tumor growth rate increased and latency decreased under circadian disruption conditions compared to normal light-dark (LD) schedules in a murine melanoma model,” write the authors. “Circadian disruption induced the loss or inversion of daily patterns of M1 (proinflammatory) and M2 (anti-inflammatory) macrophages and cytokine levels in spleen and tumor tissues. Circadian disruption also induced (i) deregulation of rhythmic expression of clock genes and (ii) of cyclin genes in the liver, (iii) increased CcnA2 levels in the tumor, and (iv) dampened expression of the cell cycle inhibitor p21WAF/CIP1, all of which contribute to a proliferative phenotype.”

The team hopes to continue exploring how circadian rhythm disruption influences immune genes and cell cycle genes in tumors.

Sources: Science Advances, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 23, 2020
Cancer
#BCSM helps physicians understand patients' needs outside the clinical setting
OCT 23, 2020
#BCSM helps physicians understand patients' needs outside the clinical setting
A new study from UCLA published in the Journal of Patient-Centered Research and Review suggests that social media can be ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 18, 2020
Cancer
Could Targeting the Proteasome be Effective Against Cancer?
NOV 18, 2020
Could Targeting the Proteasome be Effective Against Cancer?
One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical ...
DEC 21, 2020
Cancer
Examining the Bioactive Components of an Alga Against Cancer
DEC 21, 2020
Examining the Bioactive Components of an Alga Against Cancer
Many of today’s drugs come from vast libraries of synthetic compounds built by chemists for big pharma. This drug ...
JAN 12, 2021
Cell & Molecular Biology
Hyperactive Mitochondria Can Fuel Brain Tumors
JAN 12, 2021
Hyperactive Mitochondria Can Fuel Brain Tumors
The most common and deadly form of brain cancer is known as glioblastoma; the median survival time for patients is only ...
Loading Comments...